It is likely that a large fraction of PLD remains extracellular or intra-vascular with quenched fluorescence, thus accounting for the discrepancy between the negligible fluorescence in tumor sections of PLD treated mice and the quantitation of doxorubicin in tumors in the biodistribution study. This evidence concerns the gene GPLD1 and neoplasm.